XBIO-F logo

X Bioscience Stock Price

Symbol: THAMSE:XBIO-FMarket Cap: ฿230.8mCategory: Consumer Services

XBIO-F Share Price Performance

฿0.30
0.00 (0.00%)
฿0.30
0.00 (0.00%)
Price ฿0.30

XBIO-F Community Narratives

There are no narratives available yet.

XBIO-F Community Fair Values

    Recent XBIO-F News & Updates

    No updates

    X Bioscience Public Company Limited Key Details

    ฿319.2m

    Revenue

    ฿180.6m

    Cost of Revenue

    ฿138.6m

    Gross Profit

    ฿398.8m

    Other Expenses

    -฿260.2m

    Earnings

    Last Reported Earnings
    Dec 31, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.12
    Gross Margin
    43.42%
    Net Profit Margin
    -81.51%
    Debt/Equity Ratio
    31.5%

    X Bioscience Public Company Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About XBIO-F

    Founded
    1984
    Employees
    n/a
    CEO
    Saowanee Khaoubol
    WebsiteView website
    www.wowfactor.co.th

    X Bioscience Public Company Limited, together with its subsidiaries, engages in the sale of food and beverages in Thailand. The company’s brands include Kagonoya, Le Boeuf, and Bake Cheese Tart. It also engages in restaurant and energy businesses. In addition, the company manufactures and sells biological products and engages in the energy business. The company was formerly known as Wow Factor Public Company Limited and changed its name to X Bioscience Public Company Limited in January 2025. X Bioscience Public Company Limited was founded in 1984 and is based in Bangkok, Thailand.

    Thai Market Performance

    • 7 Days: 0.1%
    • 3 Months: 1.6%
    • 1 Year: -7.6%
    • Year to Date: -11.3%
    Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. Unfortunately though, the market is down 7.6% over the past year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading